English: Thank you for the two main points. On the one on parallel trading, you're right that with a weaker pound it does change different incentives to move goods around between different parts of the European Union. That's a consequence of the weakening of the pound now, and, if we are still headed towards the end of October with a serving Prime Minister threatening to break the law and to try to leave without a deal, then that is not likely to see the pound strengthen in force. There's a challenge here: with branded medicines, there are price controls, but with generic ones less so. It is something that's been raised in conversations between the Governments, and so there is awareness of that. We still think that the potential and significance of this - it's unlikely to be the case before we leave, but the challenge is that, potentially, if we leave the European Union without a deal, then we may find that generic medicines, which are typically less expensive, may actually rise in cost, particularly if there are additional checks, and additional barriers to goods, and that will be reflected in the price. So, it is a real concern. And given the significance of the drugs bill, even a small rise has a significant consequence for the finances of the health service in every part of the United Kingdom. I recognise your point about BMA members and the briefing that they've circulated. BMA members have been very clear to me about their view and their concerns. This is project reality. This is what we are faced with dealing with. Don't take my word for it, don't take what the BMA say for it, take a look at what the Yellowhammer document released actually says. No-one should be sanguine about this. It recognises the real and significant impact. The concerns are genuine. And that is why we're spending so much time, energy and effort within the Government and within our health and care services in preparing for a 'no deal' Brexit, which I completely agree with the Member should be ruled out as a wholly unacceptable outcome for any and all of us.
Welsh: Diolch am y ddau brif sylw. Ynghylch yr un sy'n ymwneud â masnachu cyfochrog, rydych chi'n iawn, mae punt wannach yn newid gwahanol gymhellion i symud nwyddau rhwng gwahanol rannau o'r Undeb Ewropeaidd. Mae hynny'n ganlyniad i'r bunt sy'n gwanhau nawr, ac, os ydym yn dal i nesáu at ddiwedd mis Hydref gyda Phrif Weinidog presennol y DU yn bygwth torri'r gyfraith ac yn ceisio gadael heb gytundeb, yna mae'n annhebygol y bydd y bunt yn cryfhau. Mae her yma: yn achos meddyginiaethau wedi'u brandio, mae rheolaethau ar brisiau, ond yn achos rhai generig mae llai o hynny. Mae'n rhywbeth sydd wedi ei grybwyll mewn sgyrsiau rhwng y llywodraethau, ac felly mae ymwybyddiaeth o hynny. Rydym yn dal i gredu mai potensial ac arwyddocâd hyn - mae'n annhebygol o fod yn wir cyn inni adael, ond yr her yw, o bosib, os byddwn yn gadael yr Undeb Ewropeaidd heb gytundeb, y gallwn ganfod y gallai meddyginiaethau generig, sydd yn nodweddiadol yn llai costus, gynyddu mewn pris mewn gwirionedd, yn enwedig os oes gwiriadau ychwanegol, a rhwystrau ychwanegol ar nwyddau, ac y caiff hynny ei adlewyrchu yn y pris. Felly, mae'n bryder gwirioneddol. Ac o ystyried arwyddocâd y bil cyffuriau, mae hyd yn oed cynnydd bach yn cael effaith arwyddocaol ar gyllid y gwasanaeth iechyd ym mhob rhan o'r Deyrnas Unedig. Rwy'n cydnabod eich sylw am aelodau Cymdeithas Feddygol Prydain a'r briff y maen nhw wedi'i ddosbarthu. Mae aelodau Cymdeithas Feddygol Prydain wedi mynegi'n glir iawn i mi eu barn a'u pryderon. Dyma realiti'r sefyllfa. Dyma'r hyn sy'n ein hwynebu. Peidiwch â chymryd fy ngair i ynghylch hynny, na gair Cymdeithas Feddygol Prydain, edrychwch ar yr hyn mewn gwirionedd a ddywed dogfen Yellowhammer a gyhoeddwyd. Ni ddylai neb fod yn obeithiol ynghylch hyn. Mae'n cydnabod yr effaith wirioneddol a sylweddol. Mae'r pryderon yn rhai dilys. A dyna pam ein bod ni'n treulio cymaint o amser, egni ac ymdrech yn y Llywodraeth ac yn ein gwasanaethau iechyd a gofal wrth baratoi ar gyfer Brexit heb gytundeb, rwy'n cytuno'n llwyr â'r Aelod y dylid diystyru hynny gan y byddai'n ganlyniad cwbl annerbyniol i ni i gyd.